Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

183 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effects of dapagliflozin in heart failure with reduced ejection fraction and chronic obstructive pulmonary disease: an analysis of DAPA-HF.
Dewan P, Docherty KF, Bengtsson O, de Boer RA, Desai AS, Drozdz J, Hawkins NM, Inzucchi SE, Kitakaze M, Køber L, Kosiborod MN, Langkilde AM, Lindholm D, Martinez FA, Merkely B, Petrie MC, Ponikowski P, Sabatine MS, Schou M, Sjöstrand M, Solomon SD, Verma S, Jhund PS, McMurray JJV. Dewan P, et al. Among authors: kosiborod mn. Eur J Heart Fail. 2021 Apr;23(4):632-643. doi: 10.1002/ejhf.2083. Epub 2021 Jan 18. Eur J Heart Fail. 2021. PMID: 33368858 Free PMC article. Clinical Trial.
Serum complement activation in congestive heart failure.
Clark DJ, Cleman MW, Pfau SE, Rollins SA, Ramahi TM, Mayer C, Caulin-Glaser T, Daher E, Kosiborod M, Bell L, Setaro JF. Clark DJ, et al. Am Heart J. 2001 Apr;141(4):684-90. doi: 10.1067/mhj.2001.113758. Am Heart J. 2001. PMID: 11275938
Dapagliflozin and days of full health lost through death, hospitalization, and impaired well-being in DAPA-HF.
Kondo T, Mogensen UM, Talebi A, Gasparyan SB, Campbell RT, Docherty KF, de Boer RA, Inzucchi SE, Køber L, Kosiborod MN, Martinez FA, Sabatine MS, Bengtsson O, Sjöstrand M, Vaduganathan M, Solomon SD, Jhund PS, McMurray JJ. Kondo T, et al. Among authors: kosiborod mn. J Am Coll Cardiol. 2024 Mar 25:S0735-1097(24)06671-3. doi: 10.1016/j.jacc.2024.03.385. Online ahead of print. J Am Coll Cardiol. 2024. PMID: 38537918
Prognostic Models for Mortality and Morbidity in Heart Failure With Preserved Ejection Fraction.
McDowell K, Kondo T, Talebi A, Teh K, Bachus E, de Boer RA, Campbell RT, Claggett B, Desai AS, Docherty KF, Hernandez AF, Inzucchi SE, Kosiborod MN, Lam CSP, Martinez F, Simpson J, Vaduganathan M, Jhund PS, Solomon SD, McMurray JJV. McDowell K, et al. Among authors: kosiborod mn. JAMA Cardiol. 2024 Mar 27:e240284. doi: 10.1001/jamacardio.2024.0284. Online ahead of print. JAMA Cardiol. 2024. PMID: 38536153
Dapagliflozin in patients with heart failure and previous myocardial infarction: A participant-level pooled analysis of DAPA-HF and DELIVER.
Peikert A, Vaduganathan M, Claggett BL, Kulac IJ, Foà A, Desai AS, Jhund PS, Carberry J, Lam CSP, Kosiborod MN, Inzucchi SE, Martinez FA, de Boer RA, Hernandez AF, Shah SJ, Køber L, Ponikowski P, Sabatine MS, Petersson M, Langkilde AM, McMurray JJV, Solomon SD. Peikert A, et al. Among authors: kosiborod mn. Eur J Heart Fail. 2024 Mar 15. doi: 10.1002/ejhf.3184. Online ahead of print. Eur J Heart Fail. 2024. PMID: 38487939
Cost Effectiveness of Dapagliflozin for Heart Failure Across the Spectrum of Ejection Fraction: An Economic Evaluation Based on Pooled, Individual Participant Data From the DELIVER and DAPA-HF Trials.
Bhatt AS, Vaduganathan M, Claggett BL, Kulac IJ, Anand IS, Desai AS, Fang JC, Hernandez AF, Jhund PS, Kosiborod MN, Sabatine MS, Shah SJ, Vardeny O, McMurray JJV, Solomon SD, Gaziano TA. Bhatt AS, et al. Among authors: kosiborod mn. J Am Heart Assoc. 2024 Mar 5;13(5):e032279. doi: 10.1161/JAHA.123.032279. Epub 2024 Feb 23. J Am Heart Assoc. 2024. PMID: 38390793 Free PMC article.
Effects of Dapagliflozin in Patients in Asia: A Post Hoc Subgroup Analysis From the DELIVER Trial.
Wang X, Lam CSP, Vaduganathan M, Kondo T, Yang M, Han Y, Pham VN, Chiang CE, Kitakaze M, Miao ZM, Jhund PS, Desai AS, Inzucchi SE, de Boer RA, Martinez FA, Kosiborod MN, Hernandez AF, Claggett B, Langkilde AM, McMurray JJV, Solomon SD. Wang X, et al. Among authors: kosiborod mn. JACC Asia. 2023 Dec 5;4(2):108-118. doi: 10.1016/j.jacasi.2023.10.005. eCollection 2024 Feb. JACC Asia. 2023. PMID: 38371292 Free PMC article.
Inter-relationships between cardiovascular, renal and metabolic diseases: Underlying evidence and implications for integrated interdisciplinary care and management.
Vora J, Cherney D, Kosiborod MN, Spaak J, Kanumilli N, Khunti K, Lam CSP, Bachmann M, Fenici P; CaReMe Global Alliance. Vora J, et al. Among authors: kosiborod mn. Diabetes Obes Metab. 2024 Feb 8. doi: 10.1111/dom.15485. Online ahead of print. Diabetes Obes Metab. 2024. PMID: 38328853 Review.
Use of Win Statistics to Analyze Outcomes in the DAPA-HF and DELIVER Trials.
Kondo T, Gasparyan SB, Jhund PS, Bengtsson O, Claggett BL, de Boer RA, Hernandez AF, Inzucchi SE, Kosiborod MN, Køber L, Lam CSP, Langkilde AM, Martinez FA, Petersson M, Ponikowski P, Sabatine MS, Shah SJ, Sjostrand M, Wilderang U, Vaduganathan M, Solomon SD, McMurray JJV. Kondo T, et al. Among authors: kosiborod mn. NEJM Evid. 2023 Nov;2(11):EVIDoa2300042. doi: 10.1056/EVIDoa2300042. Epub 2023 Oct 24. NEJM Evid. 2023. PMID: 38320525
183 results